GLP-1 Benefits Insights for HR & Employers | Embla Blog

Get smarter on your benefits

Explore insights, trends, and practical strategies to design healthcare benefits that improve outcomes, cut waste, and keep your people thriving.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

The New GLP-1 Benefit Playbook

GLP-1s are here to stay. But traditional coverage models weren’t built for them.

In this 45-minute on-demand session, Dr. Nicholas Syhler (Embla) and Sidhartha Sinha (Avant Health) walk through a new model for weight care: one that supports access, contains cost, and avoids over-reliance on medication.

Watch the Webinar

Unlocking Health Benefits from the Great Outdoors

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros.

Unlocking Health Benefits from the Great Outdoors

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros.

Unlocking Health Benefits from the Great Outdoors

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros.

Unlocking Health Benefits from the Great Outdoors

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros.

Unlocking Health Benefits from the Great Outdoors

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros.

Unlocking Health Benefits from the Great Outdoors

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros.

Unlocking Health Benefits from the Great Outdoors

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros.

Unlocking Health Benefits from the Great Outdoors

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros.

Unlocking Health Benefits from the Great Outdoors

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros.

GLP-1 coverage without the PBM: a smarter model for employers

PBM-managed GLP-1 coverage is expensive, opaque, and built around indefinite drug use. A clinically managed carve-out changes the model entirely — and the outcomes data backs it up.

Weight regain after stopping GLP-1s: the employer’s problem

Most employees who stop GLP-1s regain the weight within a year. For self-funded employers, that’s pharmacy spend without lasting outcomes — and a predictable cost cycle that a better program design can interrupt.

What is a carve-out benefit? A guide for self-funded employers

A carve-out benefit operates entirely outside your health plan. No PBM, no plan amendment, live in days. Here’s what it is, how it works, and when it makes sense for GLP-1 coverage.

GLP-1 tapering: what employers need to know

The standard assumption in GLP-1 coverage is that employees stay on medication indefinitely. A structured tapering protocol changes that — and the financial case is compelling.

The breakpoint of healthcare

Embla co-founder on AI, human connection, and the moment where healthcare must choose between perfection and humanity.

Laust Wilster Axelsen

February 19, 2026

The next phase of GLP-1s in employer health strategies

Most benefit leaders are still playing defense on GLP-1s. The employers who get this right will stop asking how to control costs and start asking how to drive real clinical and financial value.

Nicholas Syhler

February 19, 2026

Embla GLP-1 study shows same weight loss possible using 66% less Wegovy

A real-world study presented at ECO 2025 shows members in Embla’s digital program achieved the same weight loss as seen in semaglutide trials — with significantly lower doses of the drug.

Nicholas Syhler

The ultimate guide to cost-effective GLP-1 coverage for employers

Discover how employers are reducing GLP-1 costs while improving outcomes. Learn the key strategies behind sustainable coverage that actually works.

Nicholas Syhler

Should employers cover Wegovy? What the data says

GLP-1s like Wegovy are powerful — but expensive. Learn how employers can reduce costs and improve outcomes by delivering structured support and behavior change.

Nicholas Syhler

The true ROI of covering weight loss medication for employees

Learn how self-funded employers can control cost and improve outcomes by offering GLP-1s with structure, coaching, and dose management.

Nicholas Syhler

The employer's guide to launching a weight loss program that works

Learn how to design, launch, and scale a GLP-1 weight loss benefit for employees that actually delivers outcomes — without blowing your budget.

Laust Wilster Axelsen

How to add weight loss support to your employee health benefits package

Learn how employers can add GLP-1-based weight loss support to their health plans — without losing control of cost, outcomes, or operations.

Nicholas Syhler

Digital wellness programs for employers

Learn how modern digital wellness programs help employers lower costs, improve outcomes, and manage GLP-1 spend — all while delivering truly personalized care at scale

Nicholas Syhler

How to build an employee wellness initiative that actually moves the needle

Most employee wellness programs fail to deliver ROI. Learn how to build one that works — with clinically backed, behavior-first strategies that reduce claims and improve long-term health.

Nicholas Syhler

Weight loss as a benefit: why coaching + medication beats DIY apps

See why DIY apps don’t deliver sustainable weight loss — and how coaching-first programs like Embla help members lose more weight, use less medication, and reduce employer costs.

Nicholas Syhler

How Embla achieves 16.7% weight loss using 66% less GLP-1

Embla combines behavior-first coaching with strategic medication use to achieve 16.7% average weight loss using 66% less GLP-1. Here’s how our model delivers lasting results, lower spend, and better outcomes for employers.

Nicholas Syhler

Why corporate wellness programs fail — and how weight loss coaching can fix it

Most employee wellness programs underdeliver because they rely on generic tools and lack accountability. Here's why coaching-based models are different — and how employers can reduce GLP-1 spend, improve engagement, and deliver better ROI.

Laust Wilster Axelsen

Workplace heart health strategies — how employers can lower risk and boost energy

Heart disease is still the leading cause of death in the U.S. — and a silent driver of absenteeism, fatigue, and rising healthcare costs. Here's how employers can proactively support cardiovascular health and boost workforce resilience.

Nicholas Syhler

6 weight loss medication myths — and what actually works

Confusion around GLP-1s like Wegovy and Zepbound is everywhere. Here’s what employers, benefit advisors, and employees need to know about how weight loss medications really work — and what doesn’t.

Nicholas Syhler

What’s driving your GLP-1 spend — and how to get it under control

GLP-1 costs are exploding — but not for the reasons you think. Learn what’s really driving your pharmacy spend and how to control it with smarter dose management, coaching, and tapering support.

Nicholas Syhler

How to evaluate a weight loss vendor: 5 questions to ask

Not all weight loss vendors are created equal. Learn the five key questions every employer should ask to ensure clinical safety, cost control, and lasting results.

Nicholas Syhler

Why GLP-1 medication alone isn't enough (and what to offer your employees instead)

GLP-1s alone lead to short-term results — and long-term costs. Discover why coaching is critical to helping employees lose weight sustainably and reducing employer pharmacy spend.

Nicholas Syhler

How employers can offer GLP-1s without blowing the budget

GLP-1s are in demand — but open-access models lead to high costs and fragile results. Learn how self-funded employers can design a more sustainable GLP-1 benefit.

Nicholas Syhler

GLP-1s alone vs. GLP-1s + coaching: which delivers best results?

GLP-1s deliver fast weight loss — but without behavior change, results rarely last. Discover how combining medication with coaching creates better outcomes and controls long-term costs for employers.

Nicholas Syhler

The GLP-1 dilemma: how employers can cut costs while meeting demand for weight loss benefits

GLP-1 drugs like Wegovy, Mounjaro and Ozempic are highly effective — but costly. Learn how self-funded employers can reduce spend and improve outcomes with a structured, coaching-based approach.

Nicholas Syhler

Check out our learning library to boost your knowledge!

Learn how to deliver better outcomes, lower costs, and implement weight care that fits today’s workforce. For benefit leaders and cost-conscious employers.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.